Echocardiographic left ventricular geometry in hypertensive patients with electrocardiographic left ventricular hypertrophy: The LIFE study

Blood Pressure

Volumn 10, Issue 2, 2001, Pages 74-82

  Devereux, R B ^a   Bella, J ^a   Boman, K ^a   Gerdts, E ^a   Nieminen, M S ^a   Rokkedal, J ^a   Papademetriou, V ^a   Wachtell, K ^a   Wright, J ^a   Paranicas, M ^a   Okin, P M ^a   Roman, M J ^a   Smith, G ^a   Dahlof B ^a  

^a Division of Cardiology   (United States)

Author keywords

Echocardiography; Electrocardiogram; Hypertension; Hypertrophy

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOSARTAN; PLACEBO;

ADULT; AGED; ANAMNESIS; ARTICLE; BODY HEIGHT; BODY SURFACE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; ECHOCARDIOGRAPHY; ELECTRIC POTENTIAL; ELECTROCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART LEFT VENTRICLE SIZE; HEART VENTRICLE WALL; HIGH RISK PATIENT; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MULTICENTER STUDY; PATIENT SELECTION; PREVALENCE; PRIORITY JOURNAL; SEX DIFFERENCE;

AGED; CASE-CONTROL STUDIES; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; PREVALENCE; SENSITIVITY AND SPECIFICITY; VENTRICULAR REMODELING;

EID: 17844377038     PISSN: 08037051     EISSN: None     Source Type: Journal    
DOI: 10.1080/08037050152112050     Document Type: Article

References (39)

1. The role of preclinical cardiovascular disease in the evolution from risk factor exposure to the development of clinical morbid events
2. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension
3. Prognostic implications of echocardiographically-determined left ventricular mass in the Framingham Heart Study
4. The relative effects of left ventricular hypertrophy, coronary artery disease, and ventricular dysfunction on survival among black adults
5. Management of essential hypertension in patients with different degrees of left ventricular hypertrophy. Multicenter trial
6. Association of change in left ventricular mass with prognosis during long-term antihypertensive treatment
7. Prognostic significance of serial changes in left ventricular mass in essential hypertension
8. Prognostic implications of baseline electrocardiographic features and their serial changes in subjects with left ventricular hypertrophy
9. Regression of left ventricular hypertrophy as a surrogate end-point for morbid events in hypertension treatment trials
10. Reversal of left ventricular hypertrophy in hypertensive patients. A metaanalysis of 109 treatment studies
11. Reversal of left ventricular hypertrophy in essential hypertension: A meta-analysis of randomized double-blind studies
12. Treatment of Mild Hypertension Study: Final results
13. Effect of single drug therapy on reduction of left ventricular mass in mild to moderate hypertension: Comparison of six antihypertensive agents
14. The Losartan Intervention for Endpoint reduction (LIFE) Study in Hypertension. Rationale, design and methods
15. Characteristics of 9,194 patients with left ventricular hypertrophy: The LIFE Study
16. Electrocardiographic identification of increased left ventricular mass by simple voltage-duration products
17. Electrocardiographic identification of left ventricular hypertrophy: Test performance in relation to definition of hypertrophy and presence of obesity
18. Improved sex-specific criteria of left ventricular hypertrophy for clinical and computer electrocardiogram interpretation: Necropsy validation
19. Improved electrocardiographic detection of echocardiographic left ventricular hypertrophy: Results of a correlated data base approach
20. Improved electrocardiographic diagnosis of left ventricular hypertrophy
21. Comparison of enalapril vs nifedipine to decrease left ventricular hypertrophy in systemic hypertension (The PRESERVE Trial)
22. Relations of left ventricular mass to demographic and hemodynamic variables in American Indians: The Strong Heart
23. Evaluation of cardiac and vascular structure by echocardiography and other noninvasive techniques
24. The Committee on M-mode Standardization of the American Society of Echocardiography: Recommendations regarding quantitation in M-mode echocardiography. Results of a survey of echocardiographic measurements
25. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms: Recommendations for quantitation of the left ventricle by two-dimensional echocardiography
26. Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings
27. Improvements in echocardiographic LV mass measurement yield and non-randomness of missing measurements: Strong Heart and Framingham Studies
28. Strong heritability of left ventricular mass in hypertensive African-Americans and relative wall thickness in hypertensive whites: The HyperGEN Echocardiography Study
29. The association of carotid atherosclerosis and left ventricular hypertrophy
30. Reliability of echocardiographic assessment of left ventricular structure and function
31. Left ventricular mass and body size in normotensive children and adults: Assessment of allometric relations and of the impact of overweight
32. Effect of growth on variability of left ventricular mass: Assessment of allometric signals in adults and children and of their capacity to predict cardiovascular risk
33. Reference values for echocardiographic left ventricular measurements in urban and rural populations of differing ethnicity: The Strong Heart Study
34. The prognostic role of left ventricular hypertrophy in patients with or without coronary artery disease
35. Impact of different partition values on prevalences of left ventricular hypertrophy and concentric geometry in a large hypertensive population: The LIFE Study
36. Relation of arterial structure and function to left ventricular geometric patterns in hypertensive adults
37. Exercise blood pressure predicts mortality from myocardial infarction
38. Importance of obesity, race and age to the cardiac and structural effects of hypertension
39. Left ventricular hypertrophy in black versus white hypertensives: Standard electrocardiographic criteria over-estimate racial differences in prevalence